The Daily Hit: August 14, 2023
The Daily Hit is a recap of the top financial news stories for Aug. 14,
Cannabis News
Columbia Care Sees Positives in All States – Except New York
During a conference call to discuss the company’s latest earnings, Columbia Care (OTC: CCHWF) (Cboe:
Number of the Week: 23%
23% – Percentage of U.S. consumers that use concentrates Nearly a quarter of cannabis consumers
Predictions for Future Federal Cannabis Laws
By Griffen Thorne, Attorney at Harris Bricken Most Americans favor federal cannabis legalization. Nearly all Americans support medical
Enveric Biosciences Loses $6.4 Million in Q2, Announces Cost-Reduction Plan
The company said it progressed toward obtaining federal patents on synthetic psychedelic drugs. Florida-based Enveric
MindMed Gets $50M Credit Line Boost
The company already drew $15 million. Clinical stage biopharmaceutical Mind Medicine Inc. (Nasdaq: MNMD) has
Cybin Inches Closer to FDA Submission, Increases Losses in Q1
Toronto-based Cybin Inc. (NYSE: CYBN) (NEO: CYBN) increased its losses for its first fiscal quarter
Michigan Cannabis Sales Break Another Record in July, Likely to Top $3B in 2023
Prices have also rebounded since January. This story was republished with permission from Crain’s Detroit Business and
Clever Leaves Revenue Rises, Costs Fall in Q2
Clever Leaves Holdings Inc. (Nasdaq: CLVR) saw a 21% year-over-year rise for revenue in its
Glass House Shrinks Losses to $25M in Q2 on Revenue Increase
Wholesale biomass sales for Glass House were up 358% year-over-year. California-based Glass House Brands (Cboe: